Table 1.
Participant characteristics
| Group | Age (s.e.m.) (years) | Education (s.e.m.) (years) | Weight (s.e.m.) (kg) | BMI (s.e.m.) (kg/m) | Body fat (s.e.m.) (%) | Body fat (s.e.m.) (kg) | Leptin (s.e.m.) (ng/ml) | Leptin/body fat (s.e.m.) (ng/ml/kg) | glycaemia (s.e.m.) (mmol/l) | Insulin (s.e.m.) (mUl/l) |
|---|---|---|---|---|---|---|---|---|---|---|
| Lean N = 40 | 37 (2), n.s. | 6.5 (0.2) | 62 (1) | 22 (0.3) | 27 (1) | 17 (1) | 9 (1) | 0.5 (1) | 4 (0.1) | 4 (1) |
|
obese T0 N = 16 |
42 (3), n.s. | 5 (0.4) | 119 (3) | 45 (1) | 51 (1) | 62 (2.5) | 70 (7) | 1 (0.1) | 6 (0.4) | 28 (5) |
|
obese T8 N = 14 |
85 (4) | 34 (1) | 45 (1) | 42 (2) | 25 (3) | 1 (1) | 5 (2) | 10 (1) |
Mean participant socio-demographic, bodily and systemic characteristics with standard error of the mean in brackets: Patients differed significantly in all measures, except age, before (T0) and after (T8) surgery and compared to lean participants, respectively (P < 0.05, two-sampled, two-tailed t-test). Education is described as years of education after high school. Glycaemia was measured with chemiluminescent technology (Cobas®, Roche, Switzerland). Serum insulin was measured with immunoassay technology (LiaisonXL®, Diasorin, France). Serum leptin was determined using radioimmunoassay kits (Linco Research, St. Louis, MO, USA).